Intellectual Property
Apr. 6, 2007
Life After 'MedImmune'
On Jan. 9, the United States Supreme Court issued its much-anticipated decision in MedImmune Inc. v. Genentech Inc., 127 S.Ct. 764 (2007).
On Jan. 9, the United States Supreme Court issued its much-anticipated decision in MedImmune Inc. v. Genentech Inc., 127 S.Ct. 764 (2007). The 8-1 decision, with Justice Clarence Thomas dissenting, significantly eased the jurisdictional standard for declaratory judgment actions between a licensee and a patent holder. Specifically, the Supreme Court ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In